click for details →
Betoptic-S (U.S.N.L.M.)
| ||
|---|---|---|
| Dosing | 1 drop bid (q12hr) | |
| Chem Specs | betaxolol 0.25% | |
| Quantities | 2.5, 5, 10, 15ml | |
| Cost | 96.00/10ml | |
| Class | Beta 1 (cardioselective) Beta-Blocker | |
| Action | Ocular hypotensive via decrease in aqueous humor production. | |
| Usage | Indicated for the treatment of elevated IOP in patients with chronic open-angle glaucoma or ocular hypertension. |
|
| Evaluate blood pressure, pulse, neurological and respiratory status before and during treatment. |
||
| Contraindications | Sinus bradycardia, greater than a first degree atrioventricular block,
cardiogenic shock, overt cardiac failure, hypersensitivity to any component of the medication. |
|
| Pediatric use | Safety and IOP-lowering effect has been demonstrated in pediatric patients | |
| Pregnancy | Category C | |
| "S" = Suspension. Resin suspension formulation intended to extend residence time. More comfortable than but equipotent with Betoptic 0.5% solution. BAK preserved. |
||